Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats
about
Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes MellitusInnovative Thoughts on Treating Diabetes from the Perspective of Traditional Chinese MedicineThe antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological researchChinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of ActionEnhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review.Cardiovascular and metabolic effects of Berberine.From prejudice to evidence: the case of rhizoma coptidis in singaporeApplication of berberine on treating type 2 diabetes mellitus.Vinegar-Baked Radix Bupleuri Regulates Lipid Disorders via a Pathway Dependent on Peroxisome-Proliferator-Activated Receptor-α in High-Fat-Diet-Induced Obese Rats.Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance.Myricetin Increases Hepatic Peroxisome Proliferator-Activated Receptor α Protein Expression and Decreases Plasma Lipids and Adiposity in Rats.Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in miceProtection of trigonelline on experimental diabetic peripheral neuropathy.Modulating gut microbiota as an anti-diabetic mechanism of berberine.Update on berberine in nonalcoholic Fatty liver disease.Hypoglycemic herbs and their action mechanisms.Jiao tai wan attenuates hepatic lipid accumulation in type 2 diabetes mellitusChinese herbal medicine on dyslipidemia: progress and perspective.Mechanism of action of natural products used in the treatment of diabetes mellitus.Berberine-induced haemolysis revisited: safety of Rhizoma coptidis and Cortex phellodendri in chronic haematological diseases.Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.Antidiabetic properties of berberine: from cellular pharmacology to clinical effects.Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials.Effects of Brown Seaweed (Sargassum polycystum) Extracts on Kidney, Liver, and Pancreas of Type 2 Diabetic Rat Model.Metabolomics profiling to investigate the pharmacologic mechanisms of berberine for the treatment of high-fat diet-induced nonalcoholic steatohepatitis.The potential of natural products for targeting PPARα.JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial.Hepatoprotective effects of Berberis vulgaris L. extract/β cyclodextrin on carbon tetrachloride-induced acute toxicity in mice.The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients.Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism.Antidiabetic activity of extracts of Anacardium occidentale Linn. leaves on n-streptozotocin diabetic rats.Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats.Experimental diabetes treated with trigonelline: effect on β cell and pancreatic oxidative parameters.Berberine and cinnamaldehyde together prevent lung carcinogenesis.Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism.Effects of high peanut meal with different crude protein level supplemented with amino acids on performance, carcass traits and nitrogen retention of Chinese Yellow broilers.Metformin and berberine, two versatile drugs in treatment of common metabolic diseases.Interaction of herbal compounds with biological targets: a case study with berberine.Toxicological Effects of Berberine and Sanguinarine.
P2860
Q26778280-315A9FD4-47CF-4DE3-98D4-C2373B922BA3Q26778650-747D1EE1-CE7B-4A8B-8E53-B61280921520Q26851917-2334339C-B5FF-49B6-B2B4-6E6C82D144AEQ28072623-20D98279-66A0-4383-9C47-439286FB3A6AQ33773083-89CABF27-2A47-42B2-9568-BA1CBFD0E07FQ33819599-B13A6CE4-68E0-4BF2-ADE4-7E79D2C0A769Q34390654-DBADCD02-72F4-40A2-A930-766819E84A14Q34909109-2D723920-799D-46DC-B8E7-37B2AF7D75ECQ35226998-53021EBF-343C-4E07-A865-2FB30C7131A2Q35664782-1F16C67D-88BD-4F87-9C61-01DD50080D52Q35684719-395DA6F6-82CB-4151-889C-3C30E58A03ECQ35846423-D40C578B-596D-4827-A298-BFA6E01558D4Q36062928-FFC2DD3D-3A97-4060-ACFB-BBDEB3161FDFQ36477770-95A8F629-2E32-462B-AE10-9F6A749488F2Q36516516-12E742CD-20F6-428A-B763-817E6670540FQ36988577-30F94C00-FB06-4AE2-BE1F-37A61DDFCD0FQ37246475-A2CAEC87-1B2D-4B72-8043-0888E9CDFBD0Q37351506-CC64F82F-AD82-47A6-8C29-7A7BFD1FD7C7Q37618856-50766E4D-57B1-4EFC-88D5-863BD6783E18Q37914071-DF30BCC7-69DC-4C00-B4D5-6F07DE96CA6CQ37946266-9035538C-80AB-4AA6-9772-90A1CE9D8651Q37981953-318E8B2E-D1BE-4E37-AB66-6D3B75119E43Q38012073-A71CB935-155D-44AC-ACB6-0B1104C1D89EQ38025153-BFA28025-3B3B-47B2-BD23-77D1C6BD6390Q39274552-6713AD48-FAF1-444C-B00D-AA3FEDF8A2C5Q40314706-7898D7D1-290F-4D31-9D13-A3E49334E396Q41068749-EF37965A-C0A4-4496-90AE-20AF0AD30483Q41332584-567F92E1-EC3F-45BB-91E1-5AFBDE3A0661Q42021481-94095319-E87D-484A-A554-E499E219D07AQ42043970-8937D457-D1D3-429F-8438-78E2E2EBE58FQ42146973-2A12C1F4-9591-4679-932A-0EC3F55DAB62Q42374018-6F7D9F2E-67AE-4417-8D5B-81166DA23174Q44734042-67B57355-93B2-4D15-81C4-F33680A718B7Q45769262-A5D36995-C627-4C26-BBBB-F28A6CBDCEFCQ47132012-BEEF15E6-51DE-462B-ABD5-1586A9F4F4DEQ49325511-EDC0BAAD-1E69-4385-BCD8-EF16EE559406Q50877607-9A4B76AD-6A4E-4FED-B2AA-7BC9278F613BQ52668163-A37DE2A0-0CE1-4919-B2A5-0F9DEDC6617AQ53130900-B1E8FC3E-C0C1-47F5-8229-741E1959BCFDQ55252488-2D47AF43-C3F5-40C0-9803-50A179040686
P2860
Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats
description
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/06/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/06/01)
@nl
наукова стаття, опублікована в червні 2008
@uk
مقالة علمية (نشرت في يونيو 2008)
@ar
name
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@ast
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@en
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@nl
type
label
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@ast
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@en
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@nl
prefLabel
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@ast
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@en
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@nl
P2093
P356
P1476
Chronic effects of berberine o ...... n diabetic hyperlipidemic rats
@en
P2093
Dan Dan Li
Ji Yin Zhou
Jian Lin Tang
Ke Bin Zhang
Li Xia Guang
Shi Wen Zhou
P304
P356
10.1248/BPB.31.1169
P577
2008-06-01T00:00:00Z